Logo
  • Careers
  • Contact Us
  • Donate
  • Subscribe
Search
  • Home
  • About
    • About
    • Board of Directors
    • Senior Leadership
    • Financial Statements
    • Global Funding & Support
  • Our Work
    • Our Work
    • Discovery
      • HIV Vaccine Translational Research Laboratory
      • Human Immunology Laboratory
      • IAVI Neutralizing Antibody Center
      • Vaccine Design and Development Laboratory
    • Translation & Product Development
    • Clinical & Epidemiology Research
      • ADVANCE
      • Clinical Research Centers
      • Clinical Research Standards
      • HIV Epidemiology
    • Global Community Engagement
      • Africa Program
      • CASPR
      • End-User Research
      • World Bank/Japan-supported
        Partnerships | 日本政府・世銀が支援するパートナーシップ
    • IAVI DataSpace
  • Our Science
    • Our Science
    • Pipeline
    • HIV Vaccines
    • bnAbs for HIV Prevention
    • Tuberculosis Vaccines
    • Emerging Infectious Diseases Vaccines and Therapeutics
    • Snakebite
  • News & Resources
    • Latest NewsLatest News
    • Scientific Publications Scientific Publications
    • Press Releases
    • Features
    • IAVI Report
    • IAVI in the News
    • Fact Sheets & Publications
    • VOICES Newsletter
    • Media Contacts
    • Subscribe
  • Careers
  • Contact Us
  • Donate
  • Subscribe

Search

  • Home
  • About
    • About
    • Board of Directors
    • Senior Leadership
    • Financial Statements
    • Global Funding & Support
  • Our Work
    • Our Work
    • Discovery
    • Translation & Product Development
    • Clinical & Epidemiology Research
    • Global Community Engagement
    • IAVI DataSpace
  • Our Science
    • Our Science
    • Pipeline
    • HIV Vaccines
    • bnAbs for HIV Prevention
    • Tuberculosis Vaccines
    • Emerging Infectious Diseases Vaccines and Therapeutics
    • Snakebite
  • News & Resources
    • Latest NewsLatest News
    • Scientific Publications Scientific Publications
    • Press Releases
    • Features
    • IAVI Report
    • IAVI in the News
    • Fact Sheets & Publications
    • VOICES Newsletter
    • Media Contacts
    • Subscribe
COVID-19
  • Latest NewsLatest News
  • Scientific Publications Scientific Publications
  • Press Releases
  • Features
  • IAVI Report
  • IAVI in the News
  • Fact Sheets & Publications
  • VOICES Newsletter
  • Media Contacts
  • Subscribe

Latest News

Filter By:

IAVI and Merck discontinue development of COVID-19 vaccine candidate V590
PRESS RELEASES
January 25, 2021

Merck and IAVI Discontinue Development of COVID-19 Vaccine Candidate V590

Mycobacterium tuberculosis
FEATURES
January 21, 2021

TB vaccine candidate being investigated to prevent TB infection in infants in Phase III priMe study

FEATURES
January 19, 2021

IAVI at HIVR4P Virtual 2021

Tweets by @IAVI

Press Releases

December 3, 2020

IAVI Announces Launch of EDCTP-funded Socio-behavioral Project on Accessible HIV Prevention Tools for African Women

October 29, 2020

IAVI Announces Start of Clinical Trial of Next-Generation HIV Vaccine Candidate

October 27, 2020

Support from the U.S. Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says

October 22, 2020

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

August 10, 2020

IAVI and Wellcome issue a global call to action: Monoclonal antibodies for COVID-19 and other diseases could save millions of lives

See all Press Releases

Features

January 21, 2021

TB vaccine candidate being investigated to prevent TB infection in infants in Phase III priMe study

January 19, 2021

IAVI at HIVR4P Virtual 2021

December 7, 2020

Donor Spotlight: European & Developing Countries Clinical Trials Partnership

December 1, 2020

HIV Activist Winifred Ikilai: 5 Things to Know on World AIDS Day 2020

November 9, 2020

Study finds long-acting injectable HIV prevention option is effective for cisgender women

See all Features

Media Contacts

Africa

Ethel Makila
+254 71 904 3142
EMakila@iavi.org 

 

Europe

Hester Kuipers
+31 20 521 0343
HKuipers@iavi.org 

 

India

Devi Leena Bose
+91 11 4737 6031
DLeena@iavi.org 

 

North America

Rose Catlos
+1 212 847 1049
RCatlos@iavi.org 

About

About

Board of Directors

Senior Leadership

Financial Statements

Global Funding & Support

Our Work

Our Work

Discovery

Translation & Product Development

Clinical & Epidemiology Research

Global Community Engagement

IAVI DataSpace

Our Science

Our Science

Pipeline

HIV Vaccines

bnAbs for HIV Prevention

Tuberculosis Vaccines

Emerging Infectious Diseases Vaccines and Therapeutics

Snakebite

News & Resources

Latest NewsLatest News

Scientific Publications Scientific Publications

Press Releases

Features

IAVI Report

IAVI in the News

Fact Sheets & Publications

VOICES Newsletter

Media Contacts

Subscribe

icon charity navigator icon guide star icon iavi

Accessibility

Compliance

Contact IAVI

Privacy Policy

Site Map

Supplier Diversity

Terms of Use

©2021 International AIDS Vaccine Initiative. International AIDS Vaccine Initiative®, IAVI®, and the IAVI logo® are registered trademarks of the International AIDS Vaccine Initiative, Inc.